These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 28848016)

  • 1. Development of Methionyl-tRNA Synthetase Inhibitors as Antibiotics for Gram-Positive Bacterial Infections.
    Faghih O; Zhang Z; Ranade RM; Gillespie JR; Creason SA; Huang W; Shibata S; Barros-Álvarez X; Verlinde CLMJ; Hol WGJ; Fan E; Buckner FS
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.
    Critchley IA; Green LS; Young CL; Bullard JM; Evans RJ; Price M; Jarvis TC; Guiles JW; Janjic N; Ochsner UA
    J Antimicrob Chemother; 2009 May; 63(5):954-63. PubMed ID: 19258353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens.
    Jarvest RL; Berge JM; Berry V; Boyd HF; Brown MJ; Elder JS; Forrest AK; Fosberry AP; Gentry DR; Hibbs MJ; Jaworski DD; O'Hanlon PJ; Pope AJ; Rittenhouse S; Sheppard RJ; Slater-Radosti C; Worby A
    J Med Chem; 2002 May; 45(10):1959-62. PubMed ID: 11985462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational restriction of methionyl tRNA synthetase inhibitors leading to analogues with potent inhibition and excellent gram-positive antibacterial activity.
    Jarvest RL; Berge JM; Brown P; Houge-Frydrych CS; O'Hanlon PJ; McNair DJ; Pope AJ; Rittenhouse S
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1265-8. PubMed ID: 12657260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of methionyl-tRNA synthetase by REP8839 and effects of resistance mutations on enzyme activity.
    Green LS; Bullard JM; Ribble W; Dean F; Ayers DF; Ochsner UA; Janjic N; Jarvis TC
    Antimicrob Agents Chemother; 2009 Jan; 53(1):86-94. PubMed ID: 19015366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-positive antibacterial activity.
    Jarvest RL; Berge JM; Brown MJ; Brown P; Elder JS; Forrest AK; Houge-Frydrych CS; O'Hanlon PJ; McNair DJ; Rittenhouse S; Sheppard RJ
    Bioorg Med Chem Lett; 2003 Feb; 13(4):665-8. PubMed ID: 12639554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and selective inhibitors of bacterial methionyl tRNA synthetase derived from an oxazolone-dipeptide scaffold.
    Tandon M; Coffen DL; Gallant P; Keith D; Ashwell MA
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1909-11. PubMed ID: 15050625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Characterization of a Chemical Compound that Inhibits Methionyl-tRNA Synthetase from Pseudomonas aeruginosa.
    Robles S; Hu Y; Resto T; Dean F; Bullard JM
    Curr Drug Discov Technol; 2017; 14(3):156-168. PubMed ID: 28359232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic activity of the lantibiotic MU1140.
    Ghobrial OG; Derendorf H; Hillman JD
    Int J Antimicrob Agents; 2009 Jan; 33(1):70-4. PubMed ID: 18835136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of quinolinones as methionyl-tRNA synthetase inhibitors.
    Farhanullah ; Kim SY; Yoon EJ; Choi EC; Kim S; Kang T; Samrin F; Puri S; Lee J
    Bioorg Med Chem; 2006 Nov; 14(21):7154-9. PubMed ID: 16854585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase.
    Ochsner UA; Young CL; Stone KC; Dean FB; Janjic N; Critchley IA
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4253-62. PubMed ID: 16189106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
    Xiao ZP; Ma TW; Liao ML; Feng YT; Peng XC; Li JL; Li ZP; Wu Y; Luo Q; Deng Y; Liang X; Zhu HL
    Eur J Med Chem; 2011 Oct; 46(10):4904-14. PubMed ID: 21856050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
    Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of REP8839, a new antibiotic for topical use.
    Critchley IA; Young CL; Stone KC; Ochsner UA; Guiles J; Tarasow T; Janjic N
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4247-52. PubMed ID: 16189105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
    Opoku-Temeng C; Naclerio GA; Mohammad H; Dayal N; Abutaleb NS; Seleem MN; Sintim HO
    Eur J Med Chem; 2018 Jul; 155():797-805. PubMed ID: 29957525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.
    Bharatham N; Bharatham K; Lee KW
    J Mol Graph Model; 2007 Mar; 25(6):813-23. PubMed ID: 16996282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes.
    Gentry DR; Ingraham KA; Stanhope MJ; Rittenhouse S; Jarvest RL; O'Hanlon PJ; Brown JR; Holmes DJ
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1784-9. PubMed ID: 12760849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.